Reuters logo
BRIEF-Nymox Pharmaceutical posts qtrly loss $0.09/shr - SEC filing‍​
November 6, 2017 / 10:22 PM / 18 days ago

BRIEF-Nymox Pharmaceutical posts qtrly loss $0.09/shr - SEC filing‍​

Nov 6 (Reuters) - Nymox Pharmaceutical Corp

* Nymox Pharmaceutical Corp qtrly loss per share $0.09 - SEC filing‍​ Source text: (bit.ly/2j7iBgX) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below